What is the rationale for novel combination therapies?
Niels van de Donk
Information on the iwCLL 2017 meeting
Homeless tumour cells in CLL
Developments in therapies for AML - chemotherapy, targeted therapy and immunotherapy
Hagop M. Kantarjian
Can concepts from CLL be applied to other liquid and solid tumors?